Literature DB >> 21575856

ATMIN: a new tumor suppressor in developing B cells.

Xiangyu Liu1, Shan Zha.   

Abstract

Entities:  

Year:  2011        PMID： 21575856      PMCID： PMC3105463          DOI： 10.1016/j.ccr.2011.05.002

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  9 in total

Review 1.  Origin of chromosomal translocations in lymphoid cancer.

Authors:  André Nussenzweig; Michel C Nussenzweig
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

2.  ASCIZ regulates lesion-specific Rad51 focus formation and apoptosis after methylating DNA damage.

Authors:  Carolyn J McNees; Lindus A Conlan; Nora Tenis; Jörg Heierhorst
Journal:  EMBO J       Date:  2005-06-02       Impact factor: 11.598

3.  The ATM cofactor ATMIN protects against oxidative stress and accumulation of DNA damage in the aging brain.

Authors:  Nnennaya Kanu; Kay Penicud; Mariya Hristova; Barnaby Wong; Elaine Irvine; Florian Plattner; Gennadij Raivich; Axel Behrens
Journal:  J Biol Chem       Date:  2010-10-02       Impact factor: 5.157

Review 4.  Ataxia telangiectasia gene mutations in leukaemia and lymphoma.

Authors:  J Boultwood
Journal:  J Clin Pathol       Date:  2001-07       Impact factor: 3.411

Review 5.  Mechanisms that promote and suppress chromosomal translocations in lymphocytes.

Authors:  Monica Gostissa; Frederick W Alt; Roberto Chiarle
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

Review 6.  Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer.

Authors:  Martin F Lavin
Journal:  Nat Rev Mol Cell Biol       Date:  2008-10       Impact factor: 94.444

7.  Dual functions of ASCIZ in the DNA base damage response and pulmonary organogenesis.

Authors:  Sabine Jurado; Ian Smyth; Bryce van Denderen; Nora Tenis; Andrew Hammet; Kimberly Hewitt; Jane-Lee Ng; Carolyn J McNees; Sergei V Kozlov; Hayato Oka; Masahiko Kobayashi; Lindus A Conlan; Timothy J Cole; Ken-Ichi Yamamoto; Yoshihito Taniguchi; Shunichi Takeda; Martin F Lavin; Jörg Heierhorst
Journal:  PLoS Genet       Date:  2010-10-21       Impact factor: 5.917

8.  ATMIN defines an NBS1-independent pathway of ATM signalling.

Authors:  Nnennaya Kanu; Axel Behrens
Journal:  EMBO J       Date:  2007-05-24       Impact factor: 11.598

9.  ATMIN is required for maintenance of genomic stability and suppression of B cell lymphoma.

Authors:  Joanna I Loizou; Rocio Sancho; Nnennaya Kanu; Daniel J Bolland; Fengtang Yang; Cristina Rada; Anne E Corcoran; Axel Behrens
Journal:  Cancer Cell       Date:  2011-05-17       Impact factor: 31.743
  9 in total
  4 in total

1.  ATM substrate Chk2-interacting Zn2+ finger (ASCIZ) Is a bi-functional transcriptional activator and feedback sensor in the regulation of dynein light chain (DYNLL1) expression.

Authors:  Sabine Jurado; Lindus A Conlan; Emma K Baker; Jane-Lee Ng; Nora Tenis; Nicolas C Hoch; Kimberly Gleeson; Monique Smeets; David Izon; Jörg Heierhorst
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

2.  ATMIN enhances invasion by altering PARP1 in MSS colorectal cancer.

Authors:  Yue-Ju Li; Cheng-Ning Yang; Mark Yen-Ping Kuo; Wei-Ting Lai; Tai-Sheng Wu; Been-Ren Lin
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

3.  Analysis of Argonaute Complex Bound mRNAs in DU145 Prostate Carcinoma Cells Reveals New miRNA Target Genes.

Authors:  Jaroslaw Szczyrba; Volker Jung; Michaela Beitzinger; Elke Nolte; Sven Wach; Martin Hart; Sandra Sapich; Marc Wiesehöfer; Helge Taubert; Gunther Wennemuth; Norbert Eichner; Thomas Stempfl; Bernd Wullich; Gunter Meister; Friedrich A Grässer
Journal:  Prostate Cancer       Date:  2017-01-05

4.  ATMIN Suppresses Metastasis by Altering the WNT-Signaling Pathway via PARP1 in MSI-High Colorectal Cancer.

Authors:  Yue-Ju Li; Cheng-Ning Yang; Mark Yen-Ping Kuo; Wei-Ting Lai; Tai-Sheng Wu; Been-Ren Lin
Journal:  Ann Surg Oncol       Date:  2021-06-19       Impact factor: 5.344
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.